Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.7 2013 Stock Option Plan
- 4.4 License Agreement with Globe Labs Inc., Dated October 22, 2013
- 15.1 Independent Auditor?s Report, Issued by James Stafford,
- 15.2 Consent of Independent Registered Public Accounting Firm, Issued by James Stafford, Chartered Accountants
- 15.3 Independent Auditor?s Report, Issued by Leed Advisors Inc., Chartered Accountants
- 15.4 Consent of Independent Registered Public Accounting Firm, Issued by Leed Advisors Inc., Chartered Accountants
- 15.5 Annual Financial Statements As of December 31, 2013 , 2012 and 2011
- 15.6 Management's Discussion and Analysis for the Year Ended December 31, 2013
TOWTF similar filings
Filing view
External links
EXHIBIT 15.2
James Stafford
James Stafford, Inc. Chartered Accountants Suite 350 – 1111 Melville Street Vancouver, British Columbia Canada V6E 3V6 Telephone +1 604 669 0711 Facsimile +1 604 669 0754 www.JamesStafford.ca |
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation of our report dated 17 April 2014 with respect to the financial statements of Pacific Therapeutics Ltd. (the “Company”), which comprise the statements of financial position as at 31 December 2013 and the statements of loss and comprehensive loss, cash flows and changes in shareholders’ deficiency for the year ended 31 December 2013, in the Annual Report on Form 20-F of the Company dated 30 April 2014.
/s/ James Stafford
Vancouver, Canada | Chartered Accountants |
30 April 2014